Our research teams publish on innovative AI methods and advanced disease modeling to support clinical development across therapeutic areas.
Precision oncology depends on answering questions that increasingly narrow datasets cannot resolve alone. This paper introduces FRESH modeling, which combines patient-level clinical and genomic data with published trial evidence to simulate trials, generate synthetic control arms, and compare treatments across specific populations with greater speed and confidence.
Complete the form to access the white paper.
.png)
